ovarian mucinous cystadenocarcinoma
Showing 1 - 15 of 15
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +22 more
- Laboratory Biomarker Analysis
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2022
Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States
Active, not recruiting
- Ovarian Brenner Tumor
- +11 more
- Adavosertib
- +5 more
-
Duarte, California
- +15 more
Aug 11, 2022
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
Completed
- Fallopian Tube Clear Cell Adenocarcinoma
- +19 more
- Bortezomib
- +3 more
-
Hartford, Connecticut
- +13 more
Aug 8, 2019
Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Japan, United States (procedure, drug,
Completed
- Brenner Tumor
- +11 more
- adjuvant therapy
- +3 more
-
Orange, California
- +18 more
Jul 19, 2019
Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Seattle (biological,
Completed
- Fallopian Tube Cancer
- +10 more
- denileukin diftitox
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
May 13, 2019
Nausea and Vomiting, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma Trial in Hinsdale, Providence (procedure,
Terminated
- Nausea and Vomiting
- +26 more
- Adjuvant Therapy
- +7 more
-
Hinsdale, Illinois
- +1 more
Apr 24, 2018
Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Seattle (biological, drug, other)
Completed
- Brenner Tumor
- +11 more
- sargramostim
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jul 24, 2017
Malignant Ovarian Mixed Epithelial Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in
Terminated
- Malignant Ovarian Mixed Epithelial Tumor
- +7 more
- Carboplatin
- +5 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Aug 8, 2017
Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Bronx (paclitaxel, carboplatin, erlotinib)
Completed
- Brenner Tumor
- +8 more
- paclitaxel
- +2 more
-
Bronx, New YorkMontefiore Medical Center
Oct 29, 2015
Fallopian Tube Carcinoma, Malignant Ovarian Mixed Epithelial Tumor, Ovarian Brenner Tumor Trial in Philadelphia (Carboplatin,
Completed
- Fallopian Tube Carcinoma
- +10 more
- Carboplatin
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 7, 2015
Chemotherapeutic Agent Toxicity, Endometrial Adenocarcinoma, Fallopian Tube Carcinoma Trial in United States (Paclitaxel,
Completed
- Chemotherapeutic Agent Toxicity
- +14 more
-
Chicago, Illinois
- +6 more
Dec 29, 2014
Fatigue, Malignant Ovarian Mixed Epithelial Tumor, Neuropathy Trial (Acetyl-L-Carnitine Hydrochloride, Placebo, Questionnaire
Withdrawn
- Fatigue
- +12 more
- Acetyl-L-Carnitine Hydrochloride
- +3 more
- (no location specified)
Dec 29, 2014
Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach, BRCA1 Mutation Carrier Trial in Madison (veliparib, capecitabine,
Terminated
- Adenocarcinoma of the Pancreas
- +25 more
- veliparib
- +4 more
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Apr 1, 2014
Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Phoenix (paclitaxel,
Completed
- Brenner Tumor
- +8 more
- paclitaxel
- +3 more
-
Phoenix, ArizonaGynecologic Oncology Group of Arizona
Jan 23, 2013